日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Proinflammatory GSDMD activation in live macrophages and DLBCL cells marks cognate interactions and better prognosis

活巨噬细胞和弥漫性大B细胞淋巴瘤细胞中促炎性GSDMD的激活标志着同源相互作用和更好的预后。

Kong, Xue; Xu-Monette, Zijun Y; Xu, Zhenming; Hsi, Eric D; Zhao, Xiaoxian; Yan, Hui; Nunns, Harry; Au, Kelly; Visco, Carlo; Tzankov, Alexandar; Dybkaer, Karen; Yao, Shuna; Wu, Dehong; Wang, Chang; Xu, Alexander M; Pan, Zenggang; Parsons, Benjamin M; Chiu, April; Tam, Wayne; Montes-Moreno, Santiago; Zhan, Fenghuang; Bernal-Mizrachi, Leon; Zu, Youli; Zhang, Shanxiang; Møller, Michael B; Chen, Weina; Au, Qingyan; Merchant, Akil; Bhagat, Govind; Li, Yong; Young, Ken H

Prognostic gene expression and microRNA profiling signatures and genetic alterations in primary testicular diffuse large B-cell lymphoma

原发性睾丸弥漫性大B细胞淋巴瘤的预后基因表达和microRNA谱特征及基因改变

Shi, Wenyu; Xu-Monette, Zijun Y; Jia, Youchao; Tzankov, Alexandar; Go, Heounjeong; Li, Ling; Ponzoni, Maurilio; Wang, Yafei; Zhai, Qiongli; Perry, Anamarija M; Wang, Shi; Wang, Xiaoxiao; Chiu, April; Xu, Mina L; Visco, Carlo; Dybkaer, Karen; Withers, Henry; Long, Mark; Yuan, Alyssa F; Miao, Yi; Macias, Everardo; Wu, Dehong; Shuai, Wen; Wang, Bangchen; Li, Jianyong; Bhagat, Govind; Zu, Youli; Pan, Zenggang; Choi, William; Montes-Moreno, Santiago; Chen, Weina; Krieken, J Han van; Møller, Michael B; Yu, Xinfang; Parsons, Benjamin M; Zhang, Shanxiang; Hsi, Eric D; Sohani, Aliyah R; Abramson, Jeremy S; Ferreri, Andrés J M; Xu, Bing; Li, Yong; Young, Ken H

Evaluation of reference sample type for somatic variant calling in myeloid cancers

髓系肿瘤体细胞变异检测参考样本类型的评估

Jakobsen, Maja Z; Torp, Emil-August; Issa, Issa I; Høholt, Helle; Sønderkaer, Mads; Madsen, Jakob; Christensen, Lisa-Maj; Jørgensen, Maren P; Nøhr, Anne K; Brøndum, Rasmus F; Kristensen, Daniel T; Dybkaer, Karen; Severinsen, Marianne T; Due, Hanne

Tumor-Infiltrating Normal B Cells Revealed by Immunoglobulin Repertoire Clonotype Analysis Are Highly Prognostic and Crucial for Antitumor Immune Responses in DLBCL

免疫球蛋白库克隆型分析揭示的肿瘤浸润正常B细胞在弥漫性大B细胞淋巴瘤(DLBCL)中具有高度预后价值,并且对肿瘤免疫反应至关重要。

Xu-Monette, Zijun Y; Li, Yong; Snyder, Thomas; Yu, Tiantian; Lu, Tingxun; Tzankov, Alexandar; Visco, Carlo; Bhagat, Govind; Qian, Wenbin; Dybkaer, Karen; Chiu, April; Tam, Wayne; Zu, Youli; Hsi, Eric D; Hagemeister, Fredrick B; Wang, Yingjun; Go, Heounjeong; Ponzoni, Maurilio; Ferreri, Andrés J M; Møller, Michael B; Parsons, Benjamin M; Fan, Xiangshan; van Krieken, J Han; Piris, Miguel A; Winter, Jane N; Au, Qingyan; Kirsch, Ilan; Zhang, Mingzhi; Shaughnessy, John; Xu, Bing; Young, Ken H

An Aggressive Course of Transformed Splenic Diffuse Red Pulp Small B-Cell Lymphoma With Novel Somatic Loss-of-Function Mutation in RB1

一例伴有RB1基因新型体细胞功能缺失突变的脾脏弥漫性红髓小B细胞淋巴瘤转化病例,病情进展迅速。

Christensen, Lisa-Maj; Severinsen, Marianne Tang; Katoch, Pragya; Ovlisen, Andreas Kiesbye; Hoyer, Thor; Jensen, Paw; Dybkaer, Karen; Kristensen, Daniel Tuyet

Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms

利用靶向转录组和机器学习算法确定弥漫性大B细胞淋巴瘤的临床病程

Albitar, Maher; Zhang, Hong; Goy, Andre; Xu-Monette, Zijun Y; Bhagat, Govind; Visco, Carlo; Tzankov, Alexandar; Fang, Xiaosheng; Zhu, Feng; Dybkaer, Karen; Chiu, April; Tam, Wayne; Zu, Youli; Hsi, Eric D; Hagemeister, Fredrick B; Huh, Jooryung; Ponzoni, Maurilio; Ferreri, Andrés J M; Møller, Michael B; Parsons, Benjamin M; van Krieken, J Han; Piris, Miguel A; Winter, Jane N; Li, Yong; Xu, Bing; Young, Ken H

Genetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell Lymphoma

免疫微环境的遗传亚型和表型表征以及 MYC/BCL2 双表达揭示弥漫大 B 细胞淋巴瘤的异质性

Zijun Y Xu-Monette #, Li Wei #, Xiaosheng Fang #, Qingyan Au #, Harry Nunns #, Máté Nagy, Alexandar Tzankov, Feng Zhu, Carlo Visco, Govind Bhagat, Karen Dybkaer, April Chiu, Wayne Tam, Youli Zu, Eric D Hsi, Fredrick B Hagemeister, Xiaoping Sun, Xin Han, Heounjeong Go, Maurilio Ponzoni, Andrés J M Fe

Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents

具有MYC/TP53双重改变的侵袭性B细胞淋巴瘤表现出独特的临床病理生物学特征和对新型靶向药物的反应

Deng, Manman; Xu-Monette, Zijun Y; Pham, Lan V; Wang, Xudong; Tzankov, Alexandar; Fang, Xiaosheng; Zhu, Feng; Visco, Carlo; Bhagat, Govind; Dybkaer, Karen; Chiu, April; Tam, Wayne; Zu, Youli; Hsi, Eric D; You, Hua; Huh, Jooryung; Ponzoni, Maurilio; Ferreri, Andrés J M; Møller, Michael B; Parsons, Benjamin M; Hagemeister, Fredrick; van Krieken, J Han; Piris, Miguel A; Winter, Jane N; Li, Yong; Xu, Bing; Liu, Phillip; Young, Ken H

XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53

XPO1表达会加重预后不良的弥漫性大B细胞淋巴瘤(DLBCL)的病情,而当不存在突变型p53时,塞利尼索(selinexor)可有效靶向治疗DLBCL。

Deng, Manman; Zhang, Mingzhi; Xu-Monette, Zijun Y; Pham, Lan V; Tzankov, Alexandar; Visco, Carlo; Fang, Xiaosheng; Bhagat, Govind; Zhu, Feng; Dybkaer, Karen; Chiu, April; Tam, Wayne; Zu, Youli; Hsi, Eric D; Choi, William W L; Huh, Jooryung; Ponzoni, Maurilio; Ferreri, Andrés J M; Møller, Michael B; Parsons, Benjamin M; van Krieken, J Han; Piris, Miguel A; Winter, Jane N; Hagemeister, Fredrick; Alinari, Lapo; Li, Yong; Andreeff, Michael; Xu, Bing; Young, Ken H

Identification of BLNK and BTK as mediators of rituximab-induced programmed cell death by CRISPR screens in GCB-subtype diffuse large B-cell lymphoma

通过 CRISPR 筛选鉴定 BLNK 和 BTK 是 GCB 亚型弥漫大 B 细胞淋巴瘤中利妥昔单抗诱导的程序性细胞死亡的介质

Emil Aagaard Thomsen, Anne Bruun Rovsing, Mads Valdemar Anderson, Hanne Due, Jinrong Huang, Yonglun Luo, Karen Dybkaer, Jacob Giehm Mikkelsen